跳至主要内容
临床试验/NCT01160341
NCT01160341已完成4 期

Phase 4 Study of About the Effect of Testosterone Treatment on the Components of Metabolic Syndrome

Gulhane School of Medicine1 个研究点 分布在 1 个国家目标入组 312 人开始时间: 2009年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
312
试验地点
1

研究概览

简要总结

The study is designed to answer the following questions:

  1. Is hypogonadism a cause for the metabolic syndrome ?
  2. What is the effect of testosterone replacement on the metabolic parameters ?

详细描述

This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2002-2009.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 26 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Congenital hypogonadism
  • Treatment Naive

排除标准

  • Previous history of androgen replacement
  • Hypertension
  • Diabetes mellitus

研究组 & 干预措施

Testosteron, secondary hypogonadism

Experimental

干预措施: Testosteron (Drug)

研究者

发起方
Gulhane School of Medicine
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Metabolic Syndrome Criteria and the Effect of... | 临床试验